Assistant Professor, Internal Medicine, University of Michigan Medical School
Internal Medicine
Dr. Meilan K. Han, MD
|
|
Give Review
Meilan works in the field of Internal Medicine. He graduated from University of Washington School of Medicine. He over the years received 11 awards: "CMS Meaningful Use Stage 1 Certification", "Scientific Abstract Award", "Recognition Award,", "First Prize, Annual Clinical Research Training Symposium Poster Session", "Training Award", "Intern of the Month", "Election into Alpha Omega Alpha", "Hyp van Dauben Award for Excellence in Organic Chemistry", "Research Fellowship", "Honors College Scholarship" and "National Merit Finalist". Dr. Meilan K. Han is also published. He has 59 publications published. The lastest publication: "Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.' Meilan accepts Medicare.
Publications
- Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.
- Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts.
- Undiagnosed Obstructive Lung Disease in the U.S.: Associated Factors and Long-term Mortality.
- Sex-specific features of emphysema among current and former smokers with COPD.
- The Impact of Sources of Variability on Parametric Response Mapping of Lung CT Scans.
- Occupational exposures are associated with worse morbidity in patients with Chronic obstructive pulmonary disease.
- Older Adults with Chronic Lung Disease Report Less Limitation Compared to Younger Adults with Similar Lung Function Impairment.
- Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic Pulmonary fibrosis.
- Parametric Response Mapping Monitors Temporal Changes on Lung CT Scans in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
- Azithromycin: We're There!
- Childhood-onset Asthma in smokers: Association between CT measures of airway size, lung function and chronic airflow obstruction.
- Chronic Obstructive Pulmonary Disease, cognitive impairment and development of disability: The Health and Retirement Study.
- Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and In...
- Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD.
- Lung microbiome and disease progression in idiopathic Pulmonary fibrosis: an analysis of the COMET study.
- Predictors of COPD Exacerbation Reduction in Response to Daily Azithromycin Therapy.
- Computed tomographic measures of airway morphology in smokers and never-smoking normals.
- The "other" COPD.
- Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema.
- Severe chronic Bronchitis in advanced emphysema increases mortality and hospitalizations.
- The clinical impact of non-obstructive chronic Bronchitis in current and former smokers.
- Tumour necrosis factor receptor 75 and risk for COPD exacerbation in the azithromycin trial.
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).
- Update in Chronic obstructive pulmonary disease 2012.
- Sildenafil preserves exercise capacity in patients with idiopathic Pulmonary fibrosis and right-sided ventricular dysfunction.
- Genetic variants associated with idiopathic Pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
- Computed Tomographic Measures of Pulmonary Vascular Morphology in Smokers and their Clinical Implications.
- COPD treatment: time to change our algorithm?
- GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
- GOLD COPD categories are not fit for purpose in primary care - Authors' reply.
- Effect of Emphysema on CT scan measures of airway dimensions in smokers.
- Racial Differences in CT Phenotypes in COPD.
- Gender differences in symptoms and care delivery for Chronic obstructive pulmonary disease.
- Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression.
- Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in Chronic obstructive pulmonary disease.
- Contribution of the environment and comorbidities to Chronic obstructive pulmonary disease phenotypes.
- Relationship between quantitative CT metrics and health status and BODE in Chronic obstructive pulmonary disease.
- Pharmacotherapeutic approaches to preventing acute exacerbations of Chronic obstructive pulmonary disease.
- Update in Chronic obstructive pulmonary disease in 2010.
- Analysis of the Lung microbiome in the "healthy" smoker and in COPD.
- Chronic obstructive pulmonary disease phenotypes: the future of COPD.
- Cytotoxic potential of lung CD8(+) T cells increases with Chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.
- Clinical predictors of a diagnosis of idiopathic Pulmonary fibrosis.
- Lung dendritic cell expression of maturation molecules increases with worsening Chronic obstructive pulmonary disease.
- Pulmonary diseases and the heart.
- Gender and Chronic obstructive pulmonary disease: why it matters.
- Spirometry utilization for COPD: how do we measure up?
- Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic Diseases.
- Advances in critical care management of hepatic Failure and insufficiency.
- Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.
- Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
- Insight into Best Variables for COPD Case Identification: A Random Forests Analysis.
- A Simplified Score to Quantify Comorbidity in COPD.
- Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort.
- Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD.
- The association of plasma biomarkers with computed tomography-assessed Emphysema phenotypes.
- Internet access and use by COPD patients in the National Emphysema/COPD Association Survey.
- Basal Gene Expression by Lung CD4+ T Cells in Chronic Obstructive Pulmonary Disease Identifies Independent Molecular Correlates of Airflow Obstruction and Emphysema Ex...
Schools
University Of Washington School Of Medicine
University Of Mi Hosps and Health Ctrs
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asthma
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Network PCP Focus Network
- Group Employees PPO
- CareSource
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Frontpath Health Coalition
- Golden Rule
- Health Alliance
- Preferred PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- Meritain Health
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Paramount
- PHP-Physicians Health Plan
- Priority PPO
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Scientific Abstract Award
- Recognition Award,
- First Prize, Annual Clinical Research Training Symposium Poster Session
- Training Award
- Intern of the Month
- Election into Alpha Omega Alpha
- Hyp van Dauben Award for Excellence in Organic Chemistry
- Research Fellowship
- Honors College Scholarship
- National Merit Finalist
Education
-
University of Michigan Hospitals and Health Centers -
University of Washington School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1457433369 | |
| NPPES Provider LastName | HAN | |
| NPPES Provider FirstName | MEILAN | |
| NPPES Provider ZIPCode | 481095360 | |
| NPPES Provider State | MI | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 664.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 1.81 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457433369 |
| Last Name Of The Provider | HAN |
| First Name Of The Provider | MEILAN |
| View All |
Similar Doctors
|
|
Dr. Aleksandar Milovanovic, MD |
|
|
Dr. Catherine Kim, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul K. Tichenor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anand P. Patel, MD |
|
|
Dr. Houssam Y. Hariri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Corey J. Lager, MD |
|
|
Dr. Eric J. Dueweke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc L. Peters-Golden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick G. Pilie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan J. Hadley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kyle J. Gunnerson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishna Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Markus Schwaiger, MD |
|
|
Dr. Michael J. Coffey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bing Xue, MD |
|
|
Dr. Sage P. Whitmore, MD
This Doctor is OpenDoctor Recommended.
|